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1. Introduction 
1.1 Bioluminescence 
Bioluminescence is the production and emission of light by a living organism. 
Bioluminescence imaging was developed over the last decade as a tool for studying 
biological processes in living small laboratory animals by molecular imaging. The 
bioluminescence-based optical imaging is highly sensitive, low-cost, and non-invasive, 
enabling the real-time analysis of disease processes within the cell at a molecular level in 
living animals. Recent advances in protein complementation strategies have further 
expanded its applications by quantitatively monitoring several sub-cellular processes such 
as protein-protein interactions, protein dimerizations, and protein foldings. In this chapter, 
we provide a brief introduction to bioluminescence imaging technology and discuss its 
applications in studying protein-protein interactions, protein dimerizations, and protein 
foldings, which are some of the most important cellular processes that occur in the heart 
signal transduction network within the cells, by non-invasively imaging living animals.  
Molecular imaging offers many unique opportunities to study biological processes in intact 
organisms. Bioluminescence imaging (BLI) is one of several molecular imaging strategies 
currently in use for studying different biological processes.  It is based on the sensitive 
detection of visible light produced during luciferase enzyme mediated oxidation of 
substrate luciferin in the presence of several co-factors. The luciferase enzyme can be 
expressed in cells as an indicator of cellular process, and can be used to image living animals 
by developing tumor xenografts, or developing transgenic animals either to selectively 
express in a particular type of tissue using a tissue specific promoter, or in the entire animal 
by a constitutive promoter, to study different cellular diseases. The expressed luciferase 
enzyme can be imaged with an optical cooled charge coupled device (CCD) camera by 
injecting the substrate luciferin. Several bioluminescence reporters with a wide range of 
emission wavelengths are currently identified from insects and crustacean copepods  
(Table 1). Some of the proteins were even modified by changing from a few to several 
amino acids by in vitro manipulations, and achieved considerably altered proteins with 
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change in their emission wavelengths, which improved their detection sensitivity especially 
for in vivo imaging applications.  
Bioluminescence light from firefly luciferase which emits at the ~575 nm wavelength (with 
several red shifted mutants) can be imaged at a depth of several centimeters within the 
tissues, which allows at least organ-level resolution. This technology has been applied in 
several studies to monitor transgene expression, progression of infection, tumor growth and 
metastasis, tissue acceptance/rejection in transplantation, toxicology, viral infections, and 
gene therapy. BLI is simple to execute, and enables monitoring throughout the course of 
disease, allowing localization and serial quantification of biological processes without 
sacrificing the experimental animal. This powerful technique can reduce the number of 
animals required for experimentation because multiple measurements can be made in the 
same animal over time, which has the added benefit of minimizing the effects of biological 
variation in handling different groups as control. The strengths of bioluminescence reporters 
are not just limited to their applications in monitoring disease progress at the cellular level. 
The recent development of split-reporter technology has further extended their application 
to monitoring sub-cellular events such as protein-protein interactions and protein-foldings 
that are the main focus of this chapter. 
 
 
Bioluminescent 
Reporters 
Physical 
Property 
Source Emission 
Wavelength 
Substrate 
Firefly Luciferase Non-secretary Photinus pyralis 575/610nm: 
ATP/dATP 
D-Luciferin 
Beetle Luciferase Non-secretary Pyrearinus 
termitilluminans 
Red:610nm/Green: 
540nm 
D-Luciferin 
Renilla 
Luciferase 
Secretary Renilla reniformis 482nm Coelenterazine 
Gaussia 
Luciferase 
Non-secretary Gaussia princeps 480nm Coelenterazine 
Metridia 
Luciferase 
Secretary Metridia longa 480nm Coelenterazine 
Vargula 
Luciferase 
Secretary Vargula 
hilgendorfii 
478nm Vargula-
Luciferin 
Bacterial 
Luciferase 
Non-secretary Vibrio fischeri 482nm Fatty acids 
Table 1. Bioluminescent reporters currently in use for different biological applications, and 
their sources and properties 
1.2 Protein-protein interactions 
Cells are the fundamental working units of every living system. Cells determine how a 
living organism functions. The complex cellular functions rely on several fundamental 
principles. Each cell has a nucleus that contains chemical DNA (deoxyribonucleic acid) as its 
genetic material, which carries all the instructions needed to direct their activities in the 
form of functional units called proteins. Therefore, cellular functioning ultimately depends 
on the performances of different proteins. Some proteins act as building blocks, such as 
muscle proteins, while others such as enzymes control the chemical reactions within the 
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cells. Protein–protein interactions are important determining factors in the regulation of 
many cellular processes. Signaling pathways regulating cellular proliferation, 
differentiation, and apoptosis are commonly mediated by protein-protein interactions as 
well as reversible chemical modifications of proteins (e.g., phosphorylation, acetylation, 
methylation, and sumoylation), which normally control sub-cellular trafficking and function 
of proteins. To understand these modifications in proteins, and protein modification-
assisted or independent protein-protein interactions, several techniques have been 
developed and studied in intact cells and in cell extracts. The yeast two-hybrid system is one 
of the earliest techniques, which used enzyme beta-galactosidase as a reporter protein at the 
beginning, and later was improved by adopting bioluminescent reporters for rapid 
measurement. The latter is used extensively in screening for protein-protein interactions and 
also for identifying small molecule drugs that alter (inhibit or enhance) protein-protein 
interactions, which can be used as therapeutic agents for treating several cellular diseases 
including cancer. The major limitation of this system is that it can only study the protein-
protein interactions occurring in the nucleus; otherwise it requires the study proteins to be 
trafficked into the nucleus. The readout of yeast two-hybrid system is based on the amount 
of reporter proteins produced during protein-protein interaction associated transcriptional 
activation of reporter proteins (see more details in section 3.2). To circumvent this limitation, 
other techniques have been developed, including the split ubiquitin system, Sos recruitment 
system, dihydrofolate reductase complementation, -galactosidase complementation, -
lactamase complementation, the G protein fusion system, and, most recently, split-luciferase 
(firefly luciferase, click-beetle luciferase, renilla luciferase, and Gaussia luciferase) and split-
fluorescent (GFP and RFP) complementation systems.  Of these, the split-luciferase 
complementation system provides significant advantage over other systems, particularly in 
measuring protein-protein interactions in cell lysates, intact cells, and cell implants in living 
animals by molecular imaging. The firefly luciferase complementation imaging is robust and 
a broadly applicable bioluminescence approach with applications in both modification-
independent (phosphorylation, acetylation, methylation, and sumoylation) and dependent 
protein-protein interactions. 
1.3 Post genomic proteomic era 
We are in a post-genomic proteomic era. The completion of the human genome project has 
given us knowledge of the complete nucleotide sequences of human genome, their 
arrangements in different chromosomes, and the number of functional genes that are 
present in a human cell. The information collected from the human genome project along 
with other bio-informatic tools have led to several major new directions in science, including 
the characterization of RNAs (via transcriptional profiling), microRNAs, and proteins 
(proteomes). The human genome project estimated the number of functional genes in a 
human cell to range from 30,000 to 40,000. The concept of one protein, one function can 
accommodate only a limited number of functions, and does not explain the vastly more 
proteins needed by cells than those produced from the limited number of functional genes. 
The management of additional cellular functions, including various house-keeping 
functions and other specialized functions, mainly depends on the functional organ or tissue 
types to which these cells are part of. It is logical and even necessary to postulate that 
multifunctional proteins within the cell, and/or various collaborative interactions between 
proteins, are needed as molecular machines to carry out the work within a cell. To illustrate, 
the proteomes are much more dynamic and complex than the genome; it changes during 
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development in response to external stimuli, and form large interaction networks through 
which they support and regulate each other. The genetic blueprint and the genome of 
human cells are well known. However, the functions that genome encodes and program 
through which the proteins are produced by the genetic blueprint are not well understood. 
New research is only beginning to uncover the incredibly rich diversity of protein structure, 
which is much more complex than that of DNA. One new direction has sought to isolate and 
structurally characterize all the proteins that exist in the cell (Skolnick et al., 2000; Tucker et 
al., 2001). Unlike DNA, proteins have a vast repertoire of structures to carry out the 
diversity of functions. Once the proteins are identified and characterized, a second major 
challenge to find out how they assemble into the molecular machines that perform the 
cellular functions. Identifying all of the protein-protein interactions is fundamental for 
understanding the cellular processes involved in virtually all biological interactions. The 
collection of protein-protein interactions can be visualized as a map, in which proteins are 
the nodes and the circuits are the interactions. A protein-protein interaction network or map 
would then represent a search grid on which biological circuits are constructed (Tucker et 
al., 2001; Wills 2001). 
 
Fig. 1. Schematic illustration of current molecular imaging strategies, and their potential for 
providing biological informations such as anatomical details, physiological data, and 
metabolic status at the molecular level, for clinical applications in human. None of the 
current strategies is uniquely superior in independently providing different informations 
needed for making clinical decisions in diagnosis, staging and treatments especially in 
oncology, diagnosis and treatment in several other diseases; each has its strengths and 
weaknesses. 
1.4 Complexity of protein interaction networks 
There are thousands of different proteins active in a cell at any time. Many of these proteins 
are working as enzymes that catalyze the chemical reactions of metabolism, while others 
work as components of cellular machineries, such as ribosomes that read genetic 
information and synthesize proteins. Still proteins are involved in the regulation of gene 
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expression. Many proteins play their functional roles only in specific cellular compartments, 
whereas others move from one compartment to another, acting as "signals". By directly 
interacting with one another, proteins continually influence other functions (Wills 2001). In 
addition, proteins are constantly produced and degraded in cells. The rates at which these 
processes occur depend on how much of each protein is already present, how they interact 
with each other, and with other macromolecules such as DNA and RNA, and regulate the 
cellular mechanisms. One protein can speed up or slow down the rate of production of 
another by interacting with DNA or RNA, which is needed for making that particular 
protein. The interactions between different proteins that control different cellular functions 
are therefore interdependent. When a mutation causes the loss of one of these essential 
protein functions, then this can significantly affect the function of many other proteins, even 
leading to cell death (Tucker et al., 2001). Clearly the interactions between different proteins 
in a cell are much more complex than previously thought, and it is vital to understand their 
fundamental interlinked networks.  Protein–protein interactions are important determining 
factors in the control of many cellular processes such as transcription, translation, cell 
division, signal transduction, and oncogenic transformation. To modulate many of these 
cellular events, it is essential to delineate which proteins are involved and how they interact 
with one another, their precise roles in executing cellular functions, and techniques and 
mechanisms needed to manipulate these interactions for novel drug development or 
treatment strategies relevant to particular diseases. Biochemical pathways and networks 
require many different systems of dynamic assembly and disassembly of proteins with other 
proteins and nucleic acids (Michnick 2001). Much of modern biological research is 
concerned with how, when, and where proteins interact with other proteins involved in 
biological processes in the intact cellular context. The completion of the human genome 
project has added a major impetus in research that can provide simple approaches to study 
protein-protein interactions on a large scale in diseases, including cancer. 
1.5 Cellular signaling pathways  
The cellular regulatory mechanisms are interlinked. To understand the complex biological 
processes, and disease states at a molecular level, a systematic approach is necessary to 
illustrate signaling pathways. Efforts to elucidate the cellular mechanisms for different 
pathological conditions have significantly increased after the Human Genome Project. Each 
signaling pathway reacts to specific external stimuli that can be regulated by changes in 
proteins and chemicals. Recent advances in large-scale and high-throughput techniques, 
including functional genomics, proteomics, RNAi technology, and genomic-scale yeast two-
hybrid and protein complementation assays, have provided a tremendous amount of 
information on signaling pathways. To extract the biological significance from the vast data, 
it is necessary to develop an integrated environment for a formal and structured 
organization of the available information, in a format suitable for analysis with 
bioinformatics tools. To present a signaling pathway, a database must include information 
on 1) the molecules involved in signaling in response to each external stimulus, 2) which 
direction the signal is being conveyed, and 3) how the activities and sub-cellular 
localizations of molecules are changed by protein modifications and/or protein-protein 
interactions. Analyses of the first database containing such information should made it 
possible to further expand the database to understand the signaling results in processes such 
as proliferation, differentiation, and apoptosis, and to explicate how a network can be 
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composed of various signaling pathways in response to multiple external inputs. Signaling 
entities ranging from small molecules and proteins-to-protein states and protein complexes 
should be studied. It must be noted that these entities are not independent of one another. 
For instance, protein complexes are composed of proteins, and a protein binding to a small 
molecule can define a protein state. It is not surprising to find many gaps in the current 
knowledge about any particular signaling pathway. In order to organize such diverse yet 
incomplete information into a structured and coherent database, the use of a formal model 
is indispensible. Differing levels of abstraction are inter-related so that essentially the same 
signaling event can be described in detail at multiple levels. As model systems that 
implement all the parameters become available, the sharing of models with integrated 
biological data will be essential to fill in the gaps in our current knowledge base.  
1.6 Complexity in studying protein interaction networks 
There are no methods currently available to test protein-protein interaction networks, which 
occur within a cell without introducing a constructed system that mimics the function of its 
endogenous protein. It is to be expected that when a new protein of endogenous origin is 
introduced in a cell in addition to the level of its counterpart expressed inside a cell, it will 
have some direct physical effect on a number of other proteins. These new interactions may 
cause some changes in the functional aspects of several other proteins. Such effects can be 
felt right across the protein interaction network, most often becoming less significant as the 
distance of the new protein from the other protein increases. It is also possible for 
genetically modified cells to produce a new protein that will display completely new 
patterns of protein interactions. This may not be evident until the cells find themselves in 
some unusual circumstances. They may then respond in a very different way from wild-
type cells. Although the genetically engineered cells may appear to behave just like wild-
type cells, this cannot be guaranteed under all circumstances (Becker et al., 1990; Beeckmans 
1999; Bode and Willmitzer 1975). However the techniques currently available for inserting 
new DNA into the chromosomes of cells do not have any specific control mechanisms, 
capable of directing the point of insertion in the organism's existing genome without 
producing significant impact on the expression level of any of the endogenous proteins. Of 
the gene delivery systems currently available, the adeno-associated virus is the only viral 
mediated vector which can normally introduce and integrate a single copy of the transgene 
specifically into human chromosome loci at 19 (19q13.3-qter). Otherwise, it is customary to 
produce millions of cells with the new DNA inserted at essentially random positions in the 
hope of producing at least some “hits.” Screening is then conducted to find those cells, 
which must survive the engineering process and also express the newly inserted gene. These 
survivors are then subjected to further screenings to find those that seem to behave most 
like the wild-type, and yet possessing the new, desired, engineered properties. It is generally 
assumed that any harm to an organism as a result of inserting a new gene will be observed 
as a change in gross characteristics of the organism (Stopeck et al., 1998).  
1.7 Biological importance in studying protein folding 
As discussed in the previous sections, proteins are cellular macromolecules with complex 
structural and functional properties. Dysfunctional protein folding represents the 
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molecular foundation of a growing list of diseases in humans and animals. Proteins 
undergo several levels of structural alterations executed by active chaperon complexes 
(e.g., Hsp90, Hsp70) and indirectly by the inherent amino acid sequences, before they 
become a biologically active functional entity of a cell.  There is significant supporting 
evidence that associates the misfolding of proteins with several cellular diseases, 
including cancers (Table 2). Biologically representative in vitro and in vivo studies of these 
abnormal events are best suited to the discovery of molecular mechanisms to prevent or 
ameliorate such diseases. There is an active search for small molecules which assist 
refolding of misfolded proteins into their biological functional forms, as equal or at near 
equal levels of native forms, for the treatment of several biochemical disorders. However, 
thus far no current technique can be optimally extended to imaging assays in intact living 
subjects. The development of novel imaging techniques to quantitatively measure the 
level of protein misfolding in cells and in living animals, and also of small molecule 
mediated refolding, will be very useful for screening and pre-clinical evaluation of drugs 
which rectify or cure these diseases. Normally, the conformational changes in protein 
folding result in the close approximation of amino and carboxy termini in a great majority 
of native proteins, at their functionally active forms. The ‘protein folding problem’ has 
remained one of the more perplexing quandaries in fundamental biological research ever 
since the classic work of Anfinsen some four decades ago on the hydrophobic-collapse 
mechanism. How to predict the three-dimensional, biologically active, native structure of 
a protein from its primary sequence, and how a protein reaches this native structure from 
its denatured state are still unresolved questions. The intellectual conundrum of the 
folding pathway of proteins, underscored by the Levinthal paradox, has been addressed 
to some extent over the last twenty years by various proposed mechanisms for protein 
folding, including the framework model (diffusion-collision and nucleation mechanisms) 
(Anfinsen 1973; Levinthal 1969). 
There is accumulating evidence that the conditions used for refolding proteins in vitro are 
only distantly related to those found in vivo, where the physiological environment in living 
cells exerts a profound influence on protein folding owing to the involvement of the 
intracellular macromolecular background, which also contains folding catalysts and 
molecular chaperones. Aside from the relevance of the protein-folding problem to 
deciphering fundamental processes in cell biology, it is becoming clear that dysfunctional 
protein folding represents the molecular foundation of a growing list of diseases in humans 
and animals. There is mounting interest in such diseases arising from protein misfolding 
and aggregation, including Alzheimer’s disease, amyloidosis, Creutzfeldt-Jakob disease, 
cystic fibrosis and cancer, to name a few. Molecular chaperones are involved in the 
protection of cells against protein damage through their ability to hold, disaggregate, and 
refold damaged proteins or their ability to facilitate degradation of damaged proteins. Many 
of the proteins implicated in the pathogenesis of misfolding diseases escape the diverse 
chaperoning pathways that are in place to assist and assure the fidelity of correct protein 
folding. More biologically representative in vivo structural and functional studies of these 
abnormal events, carried out in the context of living cell environments, are likely best suited 
to the discovery of molecular mechanisms to prevent or ameliorate such diseases  
(Table 2)(Goetz et al., 2003). 
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Disease Mutant Protein/Protein 
involved
Molecular Phenotype 
Inability to fold 
 
  
Cystic fibrosis CFTR Misfolding/altered Hsp70 
and calnexin interactions 
Marfan syndrome Fibrilin Misfolding 
Amyotrophic sclerosis Superoxide dismutase Misfolding 
Scurvy Collagen Misfolding 
Maple syrup urine disease -Ketoacid dehydrogenase 
complex 
Misassembly/Misfolding 
Cancer p53 Misfolding/altered Hsp70 
interaction 
Osteogenesis imperfecta Type I procollagen pro a Misfolding/altered BiP 
expression 
Toxic folds 
 
  
Scraple/Creutzfeldt-jakob/ 
familial isomnia 
Prion  protein Aggregation 
Alzheimer’s disease -Amyloid Aggregation 
Familial amyloidosis Transthyretin/lysozyme Aggregation 
Cataracts Crystallins Aggregation 
 
Mislocalization owing to 
misfolding 
  
Familial 
hypercholesterolemia 
LDL receptor Improper trafficking 
1-Antitrypsin Deficiency 1-Antitrypsin Improper trafficking 
Tay-Sachs disease -Hexosaminidase Improper trafficking 
Retinitis pigmentosa 
Leprechunism 
Rhodopsin 
Insulin receptor 
Improper trafficking 
Improper trafficking 
Table 2. Examples of some putative protein misfolding associated diseases and proteins 
involved in these diseases 
2. Molecular imaging  
2.1 Role of molecular imaging in cancer research 
Molecular imaging, a new field of pharmacology that exploits the multidimensional 
approaches of light energy, has paved the way for easy understanding, interpretation, and 
manipulation of biological events at the molecular level. Molecular imaging is instrumental 
in the diagnostic aspects of various pathological conditions, and also in the evaluation of 
drugs which target specific molecular and biochemical processes in living cells and in intact 
living animals. This new field of research has flourished with the introduction of many 
novel molecular imaging probes, and genes which emit light either by reacting with a 
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substrate or with induction of light waves, as well as the advancement of sensitive imaging 
instrumentations. Imaging techniques such as positron-emission tomography (PET), single-
photon emission tomography (SPECT) with the use of radioactive tracers, and magnetic 
resonance imaging (MRI), are now widely used in the clinical observation of cancer 
pathology. Recently, the use of combinatorial techniques like PET-CT and PET-MRI are 
rapidly replacing conventional imaging methods. Positron Emission Tomography (PET) is 
an imaging technique that produces three-dimensional images of the functional processes of 
living subjects by capturing a pair of gamma rays emitted indirectly upon the injection of a 
positron-emitting radionuclide into the living body with a biomolecule.  
PET was introduced by David E. Kuhl and Roy Edwards of the University of Pennsylvania 
in late 1950s, and has been continually updated and modified to correspond to the clinical 
and research needs to work as an independent or a combinatorial device (Ter-Pogossian et 
al., 1975). It has made invaluable contributions in cancer diagnosis, treatment, and research 
by revealing tumor progression both in clinical and preclinical applications, especially in the 
diagnosis and detection of tumor metastasis. Advances in PET scanner devices and the 
introduction of novel radiotracers have fueled the progress of PET imaging. 
Fluorodeoxyglucose (18F-FDG), an analogue of glucose, is the most common radiotracer 
used for PET imaging, because it can reveal specific tissue metabolic activity. However, 18F-
FDG is phosphorylated by hexokinase and the phosphate cannot be cleared in most tissues, 
which can result in intense radiolabeling of tissues with high glucose uptake (Burt et al., 
2001). FDG-PET is widely used in clinical oncology for diagnosis, staging and follow-up 
after treatment of tumors. Tissue and also molecule-specific radiotracers have been 
introduced to monitor the expression level of structural and functional proteins (Torigian et 
al., 2007). Steroid receptors have been associated with the growth of breast tumors, and thus 
understanding the receptor status is essential for the treatment of breast cancer. 
Radiolabeled ligands and their analogues are in preclinical application for receptor imaging. 
18F-fluro-17┚-estradiol (FES) has been used in PET imaging to examine the estrogen receptor 
status in different tissues of living subjects (Mintun et al., 1988). Bombesin, a peptide 
isolated from the frog Bombinas bombina, binds with gastrin-releasing peptide (GRP) receptor 
and has been implicated in breast cancer. This property has led the development of 
radiolabeled bombesin for peptide receptor imaging in breast cancer diagnosis (Scopinaro et 
al., 2002). 
Single Photon Emission Computed Tomography (SPECT) is another imaging technique that 
is similar to PET imaging.  Unlike PET, however, the tracer used in SPECT emits gamma 
rays that can be measured directly. In SPECT, the 2-D view of 3-dimensional images is 
acquired by a gamma camera and eventually 3-D data set is generated with the use of 
computer based tomographic reconstruction algorithm. Magnetic Resonance Imaging (MRI) 
is another widely used imaging technique, but unlike PET and SPECT, MRI can be used to 
view the anatomical nature of living subjects by generating data about the functional status 
of tissues (MacDonald et al., 2010). Magnetic Resonance Imaging (MRI) is a well-established 
diagnostic method to detect cancer. It has been widely used to detect breast cancer as it 
produces the highest sensitivity in spatial resolution of all imaging modalities. Guinea et al. 
(2010) investigated and analyzed the possible relationship between the magnetic resonance 
imaging (MRI) features of breast cancer and its clinicopathological and biological factors 
such as estrogen and progesterone receptor status, and expression of p53, HER2, ki67, 
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VEGFR-1, and VEGFR-2 (Fernandez-Guinea et al., 2010). Their results did not show a 
significant association between the MRI parameters and any of the biological factors 
included in the study.  By contrast, other reports have shown that high spatial dynamic MRI 
of morphological or kinetic analysis are associated with prognostic factors such as 
expression of estrogen receptor (ER), expression of progesterone receptor (PR), and 
expression of p53, c-erbB-2, and Ki-67 (Fernandez-Guinea et al., 2010,  Szabo et al., 2003) 
found that rim enhancement pattern, early maximal enhancement, and washout phenomena 
are associated with the poor prognostic factors of histological differentiation, high Ki-67 
index, and negative PR expression status (Szabo et al., 2003). It was suggested that these MR 
images could be useful in the prognosis of breast cancer. The MR signals may also be used 
to noninvasively identify highly aggressive breast carcinomas and help differentiate 
between benign and malignant lesions. The difference in contrast enhancement has been 
associated mainly with a higher vascular permeability in tumors, and the overexpression of 
c-erbB2 in tumor cells is closely linked to increased expression of vascular endothelial 
growth factor (VEGF) and Ki-67 in proliferation (Szabo et al., 2003). 
Similar to nuclear and magnetic imaging modalities, optical imaging has also made a sizable 
contribution in medical imaging (Weissleder and Pittet 2008). Fluorescence and 
bioluminescence methods are used as a source of contrast in optical imaging, but a major 
setback in optical imaging is the lack of penetration depth, which prevents its wide clinical 
applications in humans. Near infrared (NIR) imaging has been identified as a useful optical 
imaging technique because of the lower absorption coefficient of tissue to light in near 
infrared region. Radiolabeled antibodies have been evaluated for breast cancer diagnosis 
since 1978 with tumor associated antigens such as carcinoembryonic antigen (CEA) and the 
polymorphic epithelial mucin antigen (MUC1) (Goldenberg et al., 1974). They were widely 
used in studies of immunolocalization and radioscintigraphy. Clinically, affinity purified 
131I-labeled goat anti-CEA IgG was subjected in selective breast tumor targeting (Goldenberg 
and Sharkey 2007). CEA-Scan with Arcitumomab, an US FDA approved anti-CEA antibody, 
could detect breast cancer that has been missed by mammography. In addition, antibodies 
against the HER2/neu receptor have also been investigated in detail either as therapeutic 
and/or diagnostic agent. Biotinylated anti-HER2/neu antibodies have been used to increase 
the contrast of MR images when they bind with avidin-gadolinium complexes (Artemov et 
al., 2003). The 111In labeled Trastuzumab (Herceptin) Fab has been identified as a selective 
imaging agent to localize HER2/neu receptor in small BT-474 tumors (Tang et al., 2005).  
2.2 Reporter gene imaging in living animals  
Molecular imaging is a rapidly expanding field that attempts to visualize fundamental 
molecular/cellular processes in living subjects (Gambhir 2002; Massoud and Gambhir 2003; 
Weissleder 2002). Imaging molecular events in cells in their native environment within the 
living subjects probably result in the least amount of perturbation of normal signaling 
processes. However, this advantage of non-invasive imaging has a trade-off.  For example, 
most current techniques do not have single cell resolution at any significant depth within 
the animal. Instead, bulk signals from large numbers of cells (hundreds to millions) are 
needed. Newer methods that allow the observation of single cells within living subjects are 
under active investigation, but are more invasive in nature (Jung and Schnitzer 2003; Mehta 
et al., 2004). To produce a signal detectable outside the animal subject, the cells located 
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inside the subject must produce a signal of sufficient intensity. The signal may come from a 
fluorescent protein excited at the correct wavelength, the interaction of a bioluminescent 
protein with its substrate (Figure 2), or from radiolabeled substrates that emit a signal in the 
form of gamma rays. For optical signals, red light and near infrared light have the best 
tissue penetration, and are therefore preferred. For radiation-based signals, the use of single 
photon emitters and positron emitters generating gamma rays are favored. It is not possible 
to use beta emitters (e.g., 3H), due to their minimal tissue penetration. The focus of this 
chapter is primarily on optical technologies for imaging protein-protein interactions. 
Although other approaches such as microPET can be used for imaging protein-protein 
interactions (Luker et al., 2002a; Massoud et al., 2010), the much lower cost, higher 
throughput, and greater sensitivity of optical imaging in small animals favor its use for 
imaging protein-protein interactions. Additional discussions of other small animal imaging 
technologies including microPET may be found elsewhere (Cherry and Gambhir 2001; 
Massoud and Gambhir 2003). 
 
 
Fig. 2. Schematic illustration of the principle of optical bioluminescence imaging in cells. In 
this strategy mammalian cells are labeled to express bioluminescent protein under a 
constitutive (CMV, LTR, Ubiquitin, or CAG) or tissue-specific or an inducible promoter, 
either by transfecting a plasmid with chemical agent (Liposome) or transduced with a viral 
vector (Lentivirus, Adenovirus, Retrovirus, or Adeno-associated virus). The cells can be 
allowed to express luciferase protein for a particular period of time and imaged by exposure 
to substrate luciferin in intact cells, or can be measured by luminometer in cell lysates by 
adding luciferin and other co-factors. 
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There are two primary types of optical imaging systems for living subjects: a) fluorescence 
imaging, which use emitters such as green fluorescent protein (GFP), wavelength-shifted 
GFP mutants, red fluorescent protein (RFP), “smart” near-infrared fluorescent (NIRF) 
probes, and b) bioluminescence imaging, which utilizes a specific enzyme-substrate reaction 
such as Firefly luciferase/D-Luciferin, Renilla luciferase/coelenterazine (Bhaumik and 
Gambhir 2002a; Contag and Ross 2002; Tung et al., 1999) and several other bioluminescent 
proteins with the respective substrates (Substrates and properties are shown in Table 1). 
Emission of light from fluorescent markers requires external light excitation, while 
bioluminescence systems generate light de novo after an injectable substrate is introduced. In 
both cases, emitted light can be detected with a thermoelectrically cooled charge-couple 
device camera (CCD), which can detect light in the visible light range (400 nm to 750 nm) to 
near-infrared range (~800 nm) (Figure 3). Cooled to -120 to -150C, these cameras are 
exquisitely sensitive to even weak luminescent sources within a light-tight “black-box” 
 
Fig. 3. Scheme of optical imaging (bioluminescence and fluorescence) in living animals. In 
this strategy, mammalian cells stably expressing bioluminescent or fluorescent proteins are 
implanted in animals (orthotopic or xenograft) and allowed to grow the tumors. The 
animals were imaged by exciting with respective excitation wavelength of the protein used 
for labeling in fluorescence imaging. The emitted light was captured by an optical cooled 
charge coupled device camera, and quantitated by compatible software provided with the 
system. Similarly, in bioluminescence imaging, the animals were injected with the respective 
substrate of the bioluminescent reporter used for labeling the cells, and light emitted from 
the tumor cells is collected without passing through filters. 
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chamber, allowing for quantitative analysis of the data. The method of imaging 
bioluminescence sources in living subjects with a CCD camera is relatively straightforward: 
the animal is anesthetized, injected intravenously or intraperitoneally with the substrate, 
and placed in the light-tight chamber for a few seconds to minutes. A standard light 
photographic image of the animal is obtained, prior to a bioluminescence image captured by 
the cooled CCD camera positioned above the subject within the confines of the dark 
chamber. A computer subsequently superimposes the two images on one another, and 
relative location of luciferase activity is inferred from the composite image. An adjacent 
pseudocolor scale indicates relative or absolute number of photons detected. This scale does 
not reflect the color (wavelength) of the emitted photons, but only the number of such 
photons, measured in relative light units per minute (RLU/min). At present, the primary 
disadvantage of fluorescence as compared to bioluminescence is the background level of 
auto-fluorescence of tissues in the former approach. However, methods are being developed 
to correct for auto-fluorescence and may allow greater use of fluorescence in the study of 
protein-protein interactions in living subjects. To date, the initial validation of in vivo 
imaging has been based primarily on bioluminescence. If auto-fluorescence issues can be 
minimized, then it may be possible to image multiple interactions using different fluorescent 
reporters. Comparison of optical-based imaging systems with the other imaging modalities, 
such as the radionuclide-based or MRI-based systems, reveals important differences. One 
major advantages of optical-based reporter systems is that they are at least an order of 
magnitude more sensitive than the radionuclide-based techniques at limited depths (Ray et 
al., 2003). Furthermore, the direct and indirect costs of optical systems are generally less 
than radionuclide-based techniques or MRI.  However, significantly less spatial information 
is obtained from optical imaging, and the signal obtained from light-emitting reporter 
systems is limited by the tissue depth from which it arises. Furthermore, while significant 
progress has been made to localize fluorescent signals tomographically to obtain 
distribution of fluorochromes in deep tissues (Ntziachristos et al., 2002), there are currently 
only prototype instruments to obtain three-dimensional localization of the targeted optical 
probes. 
2.3 Optical reporter genes to image cellular process in small animal models 
Luciferases are enzymes that emit light when they react with a specific substrate. A diverse 
group of organisms make use of luciferase-mediated bioluminescence. Luciferases that 
catalyze the light emitting reactions of fireflies, coelenterates, or bacteria show no nucleotide 
homology to each other. The substrates (i.e., luciferins) of these reactions are also chemically 
unrelated (Wilson and Hastings 1998). All these bioluminescent reactions combine 
molecular oxygen with luciferin, to form a luciferase-bound peroxy-luciferin intermediate. 
This, in turn, releases photons of visible light (Wilson and Hastings 1998) over an emission 
spectrum range between 400 and 620 nm. Experimentally, the emitted light is used as a 
"reporter" for the activity of any regulatory elements that control expression of luciferase. 
Firefly luciferase (FLUC), cloned in 1985 from the firefly Photinus pyralis, is now emerging as 
the gene of choice for in vivo and in vitro reporting of transcriptional activity in eukaryotic 
cells (de Wet et al., 1985). FLUC emits light from green to yellow in the presence of D-
Luciferin, ATP, magnesium, and oxygen. The short half-life and fast rate of turnover of 
FLUC (T1/2 ~ 3 h) in the presence of D-Luciferin allows for real-time measurements, because 
the enzyme does not accumulate intracellularly to the extent of other reporters; thus, the 
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relationship between the enzyme concentration and the intensity of emitted light in vitro is 
linear up to 7-8 orders of magnitude. These properties potentially allow for sensitive non-
invasive imaging of FLUC reporter gene expression in living subjects (Massoud et al., 2004; 
Wu et al., 2002). In recent years, considerable work with non-invasive imaging of firefly 
luciferase has been carried out (Bhaumik and Gambhir 2002b; Contag et al., 2000; Contag et 
al., 1997; Contag et al., 1998; Jawhara and Mordon 2004; Paulmurugan et al., 2002b; Ray et 
al., 2002a; Wu et al., 2002; Wu et al., 2001).  
The use of a second bioluminescent reporter [(Renilla Luciferase (RLUC)] with different 
substrate utility than firefly luciferase, has allowed for monitoring of more than one process 
at a time in mammalian cells. Renilla luciferase (RLUC), originally cloned and sequenced 
from the sea pansy, Renilla reniformis, by Lorenz et al. (Lorenz et al., 1991), has been used as 
a marker of gene expression in bacteria, yeast, plant and mammalian cells (Lorenz et al., 
1996). RLUC is widely distributed among coelenterates, fishes, squids and shrimps 
(Hastings 1996). The enzyme RLUC catalyzes oxidation of its substrate, coelenterazine, 
leading to bioluminescence. Coelenterazine has an imidazolopyrazine structure [2-(p-
hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo [1, 2-a] pyrazin-3- (7H)-on], and 
upon oxidation, releases blue light across a broad range, peaking at 480 nm (Wilson and 
Hastings 1998). However, the native RLUC protein has some inherent limitations when used 
in mammalian cells. Ten percent of its codons are associated with poor translation in 
mammalian cells, limiting expression efficiency. Also, the presence of a large number of 
potential transcription factor binding sites within RLUC sequences can cause anomalous 
transcriptional behavior in mammalian cells. For many in vivo imaging applications, 
researchers have utilized a synthetic Renilla luciferase reporter gene (hRLUC) that has been 
codon optimized for efficient translation in mammalian cells. In addition, deletion of poly 
(A) signals (AATAAA) and incorporation of a Kozak sequence at the beginning of the gene 
contributed to a better expression. The resulting reporter gene has a higher transcriptional 
efficiency, which enhances the detection of the reporter enzyme in cell culture and living 
animals (Bhaumik et al., 2004).  
After a long lag time, recently several other luciferases with different properties have been 
isolated. Gaussia luciferase (GLUC) with its secretary property has been recently used for 
secretary biomarker identification and validation in human cancers. As GLUC uses the same 
substrate (coelenterazine) as RLUC and emits light in a similar wavelength (480nm), but 
differs in its secretary property, its use has been limited in several applications. Similarly, 
Metridia luciferase, with similar substrate utilization, emission wavelength and secretary 
property as GLUC, has been identified, but it has not added much to the field of 
bioluminescence imaging in living animals. Recent isolation of another luciferase (Vargula 
luciferase) with similar physical properties (secretary, emits light at 480nm) as GLUC, but 
uses a different substrate (Vargula luciferin), has the advantage of adding another 
bioluminescent protein for multiplexing different bioluminescent reporters to enable 
simultaneous monitoring of several biological processes in cells and in living animals.  
3. Bioluminescent assays to study protein-protein interactions 
As we discussed briefly in section 1.6 the different assays currently available for studying 
protein-protein interactions, in this section we further explain how these assay systems 
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work, and discuss the advantages most of these assays have over other complementary 
systems, and their contributions to the field of molecular imaging in disease monitoring and 
drug development processes.  
3.1 Yeast two-hybrid system to study protein-protein interactions 
Protein-protein interactions play vital part in almost all biological processes. Large networks 
of interacting proteins control many important regulatory pathways. A full understanding 
of any pathway or cellular processes will require a map of the binary interactions among the 
proteins involved. One of the most widely used methods to detect biologically important 
protein-protein interactions is the yeast two-hybrid system (Fields and Song 1989). In a two-
hybrid assay, the two proteins are expressed in yeast one fused to a DNA-binding domain 
(BD) and the other fused to a transcription activation domain (AD). If the two proteins 
interact, they activate transcription of one or more reporter genes that contain binding sites 
of the BD. Investigated first in yeast, this classical two-hybrid system was later adopted for 
mammalian cells with certain modifications (Luo et al., 1997). When expressed 
simultaneously in the same cell, the interactions between the two mammalian proteins bring 
the activation domain (VP16) and binding domain (Gal4) together that in turn bind to the 
Gal4 domain binding sequences followed by a reporter gene. High levels of reporter gene 
expression will indirectly indicate the physical interactions between the proteins of interest. 
Most of the approaches used for high-throughput two-hybrid studies have been limited to 
in vitro assays and cultured cells that do not represent the actual scenario in intact animal, as 
well as being unable to predict the kinetics of the interaction. Thus, the development of 
methods to non-invasively and repetitively image protein-protein interactions using the 
mammalian two-hybrid system in living animal would significantly increase our knowledge 
on the intricacy and complexity of different regulatory pathways.  
To overcome these problems, we and others have developed a modified mammalian two-
hybrid system to detect protein-protein interactions in living mice using bioluminescence 
and positron emission tomography (PET) imaging techniques (Luker et al., 2002b; Luker et 
al., 2003; Ray et al., 2002b). To demonstrate the use of this system for imaging in living 
animals, the two known interacting proteins, ID and MyoD, were used. These two proteins 
strongly interact in vivo during muscle generation (Ray et al., 2002b). To modulate the 
expression of these two fusion proteins (ID-GAL4 and MyoD-VP16), we used the NF-kB 
promoter to drive expression of the Id-gal4 and/or myoD-vp16 fusion genes, and utilize 
TNF- to induce the NF-kB promoter that controls the expression level of fusion proteins in 
response to TNF- dose. The reporter construct comprised of five GAL4 binding sequences 
followed by the firefly luciferase reporter gene. In cell culture, co-transfection with the 
effector and reporter plasmids with variable levels of expression regulated by TNF- show 
induction in FLUC activity. The FLUC activity directly correlate with the interaction 
between the proteins used, which are Id and myoD in this case. By replacing these two 
proteins, it is possible to look for other proteins that are currently not known for their 
interactions (Figure 4).  
A similar system was developed for a tetracycline inducible bi-directional vector carrying 
two other proteins (the tumor suppressor p53 gene and SV40-T antigen) by other groups 
(Luker et al., 2002b; Luker et al., 2003). Interactions of p53 and SV40-Tag proteins after 
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doxycycline induced expression resulted in formation of the VP16-Gal4 trans-activator 
complex that binds to the Gal4 binding sequences driving expression of a HSV1-sr39TK-GFP 
reporter fusion protein. Expression of GFP (fluorescence imaging) is detected at the level of 
single cell, and expression of HSV1-sr39TK is imaged in living mice with microPET. Clones 
of HeLa cells stably expressing both the reporter plasmid and the bi-directional effector 
plasmid are isolated, and levels of interacting proteins are measured with increasing doses 
of doxycycline and further confirmed by western blots, thymidine kinase radiotracer assays, 
and fluorescence microscopy. Promising cell culture studies have led to further 
investigations into the protein-protein interactions in living mice using different modalities 
in cells and in vivo in living animals. 
 
Fig. 4. Scheme of a single vector mammalian two hybrid system to study protein-protein 
interactions. The vector is designed to have several components needed for measuring protein-
protein interaction. In this strategy, the vector expresses two fusion proteins under two 
separate promoters. They can be either constitutive or inducible. One fusion protein contain 
Gal4-DNA binding domain (Gal4-DBD) expresses with one of the study protein (Gal4-DBD-
Protein-X), and the other one expresses a small transactivating peptide derived from herpes 
simplex virus thymidine kinase (HSV1) with another protein (Protein-Y-VP16). The same 
vector has a specific DNA sequence repeated five times on which the Gal4-DBD can bind, and 
a minimal promoter (TATA box), followed by a reporter gene (Luciferase). This minimal 
promoter will not express any reporter protein until the Gal4-DBD binds to it and brings the 
VP16 domain fused to another fusion protein by protein-protein interactions. The amount of 
luciferase expression directly relate to the interaction which occurs between proteins X and Y.  
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However, both the two-hybrid (TNF- and tetracycline inducible) approaches have several 
limitations. Both use strong and constitutively (spontaneous) interacting proteins and are 
unable to fully address weakly associated proteins or proteins with differential binding 
affinity, and also to decipher the time-kinetics of protein-protein interactions. Moreover the 
two-hybrid system could only detect the interacting proteins in the nucleus, not in the 
cytoplasm where the largest pool of protein-protein interactions responsible for many 
regulatory pathways occur. It is hoped that by combining non-invasive imaging approaches 
involving detection of cytoplasmic protein-protein interaction (through protein 
complementation study, split reporter strategy, FRET/BRET study etc.) with the two-hybrid 
system, it will be possible to measure the complete spectrum of the pharmacokinetics and 
pharmacodynamics of protein interactions in different regulatory pathways, as well as to 
perform screening and pre-clinical evaluation of small molecule drugs for therapeutic 
applications. 
3.2 Bioluminescent reporter protein complementation assays to study protein-protein 
interaction  
Protein complementation assays with split luciferases (split Firefly, split Renilla, and split-
Gaussia luciferases) are highly useful techniques for studying protein-protein interactions. 
Functional proteins can be assembled from one or more non-covalently attached 
polypeptides, with the efficiency of assembly a measure of real time protein-protein 
interactions, both in cells and in living animals. As discussed before, -galactosidase from 
Escherichia coli is one of the first enzymes used extensively as an experimental reporter, 
long before the discovery of several other reporter proteins such as Chloramphenicol 
Acetyl Transferase (CAT), luciferases, and fluorescent proteins. Active -galactosidase is a 
tetramer that hydrolyzes terminally non-reduced -galactose residues in sugars, 
glycoproteins, and glycolipids (Hucho and Wallenfels 1972; Johnsson and Varshavsky 
1994a; Johnsson and Varshavsky 1994b; Loontiens et al., 1970; Nichtl et al., 1998; Stagljar 
et al., 1998). The identification of the -complementation process of -galactosidase 
opened up the idea of using protein fragments coupled with an enzymatic assay to gauge 
protein interactions (Hodges et al., 1992; Ullmann et al., 1968). Each monomer of the 
tetramer can be cleaved into a small N- terminal -fragment (50-90 residues) and a large 
(135 kDa fragment) -fragment. Addition of purified -fragment to dimers of 
enzymatically inactive purified -fragments forms an active tetrameric enzyme, in a 
process called -complementation (Hodges et al., 1992; Kippen and Fersht 1995; Smith 
and Matthews 2001; Ullmann et al., 1968). This process suggests that synthetically 
separated fragments of a single polypeptide might complement each other, and give rise 
to an enzymatically active protein, particularly if the interaction is aided by fusion of the 
halves to strongly interacting moieties. In the “split protein” strategy, a single reporter 
protein/enzyme is cleaved into N-terminal and C-terminal halves; each half is fused to 
one of two interacting proteins, X- and Y. Physical interactions between the two proteins 
reconstitute the functional reporter protein, leading to enzymatic activities that can be 
measured by in vitro or in vivo assays. This split protein strategy can work either through 
protein-fragment complementation assays, or intein-mediated reconstitution assays 
(Ozawa et al., 2001). To date, a number of different reporter proteins (-lactamase, -
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galactosidase, ubiquitin, dihydrofolate reductase, firefly luciferase, renilla luciferase, 
Gaussia luciferase, etc.) have been adapted for split-protein strategies. Advantages of this 
approach include its ability to monitor the interaction of proteins occurring in their 
specific cellular compartments, utility for drug evaluation, low background, ability to 
measure real-time interactions, applications in protein array analysis, and potential 
adaptability to study both cells and in living animals. However, not every reporter protein 
can be used for this strategy (Ozawa et al., 2001; Paulmurugan et al., 2004; Pelletier et al., 
1999; Remy and Michnick 1999; Rossi et al., 1997; Wehrman et al., 2002) (Figure 5).  
 
 
Fig. 5. Scheme of a split-reporter protein complementation system for studying protein-
protein interactions. (A). Complementation system to study spontaneous protein-protein 
interactions. In this strategy, N- and C- terminal firefly luciferase reporter protein fragments 
are attached to two study proteins and are expressed as individual fusion proteins (N-
FLUC-Protein-X and Protein-Y-C-FLUC). When cells are transfected to co-express these two 
fusion proteins, the interaction between protein-X and protein-Y brings the N-FLUC and C-
FLUC fragments to a close proximity and induces the complementation to produce reporter 
signal. (B). Complementation system to study small molecule mediated protein-protein 
interactions. In this strategy N- and C- terminal Renilla luciferase reporter protein 
fragments are attached to two study proteins and are expressed as individual fusion 
proteins (N-hRLUC-Protein-A and Protein-B-C-hRLUC). When cells are transfected to co-
express these two fusion proteins, the interaction between protein-A and protein-B is 
induced by a small molecule drug, which brings the N-hRLUC and C-hRLUC fragments to a 
close proximity and causes the complementation to produce reporter signal. In both 
strategies, the amount of luciferase signals produced through complementation directly 
relates to the interaction which occur between proteins X and Y or A and B (Paulmurugan 
and Gambhir 2003; Paulmurugan et al., 2009).  
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We made several combinations of N- and C- terminal fragments of the FLUC, RLUC, and 
GLUC enzymes by a semi-rational dividing approach and used these fragments for protein-
protein interactions and protein folding studies.  These fragments have been efficiently used 
in complementation assays for the detection of insulin-mediated phosphorylation, as 
gauged by the subsequent interaction of insulin receptor substrate peptide and its 
interacting partner SH2 domain of PI-3kinase (Ozawa et al., 2001). They have also been used 
to detect the interactions of the myogenic differentiation proteins Id and MyoD, in both cell 
culture and non-invasive repetitive optical imaging in living mice (Paulmurugan et al., 
2002b). Separately, Luker et al., have also described a systematic truncation library yielding 
alternative complementary N- and C- fragments of FLUC. These fragments were used to 
monitor rapamycin-mediated interactions of rapamycin binding proteins (Luker et al., 2004). 
We also have used our FLUC fragments to study Rapamycin-mediated interactions, and 
found the complementation to be too weak for imaging in living animals by optical CCD 
camera.   
RLUC and GLUC are the smallest optical bioluminescent reporter proteins, and we have 
identified several split sites for these proteins and found selective combinations that are 
efficient for studying protein-protein interactions through a protein fragment 
complementation strategy. This reporter protein, when rationally split (RLUC: between 
residues 229 and 230 or 235 and 236; GLUC: between 105 and 106) (Paulmurugan and 
Gambhir 2003), functions efficiently in both cell culture and in living animals, as we have 
demonstrated with several different protein partners. Fragments generated by splitting 
between residues 229 and 230 for RLUC and 105 and 106 for GLUC, were used to study 
rapamycin-induced interactions of human proteins FRB (FKBP12 Rapamycin Binding 
domain) and FKBP12 (FK506 Binding protein) (Paulmurugan et al., 2004), and also the 
inherent homodimerization property of mutant HSV1-sr39TK (Massoud et al., 2004). One 
limitation associated with the use of both RLUC and GLUC is their relatively rapid reaction 
kinetics, requiring early time-point measurements (Bhaumik and Gambhir 2002a). 
Nevertheless, this split reporter system appears highly suitable for studying protein-protein 
interactions in cell culture and in living animals owing to its strong optical bioluminescence, 
generating a signal that is amplifiable through an enzymatic process.  
3.3 Bioluminescent reporter protein complementation assay to study protein folding 
As we discussed in section 1.7, techniques for studying protein foldings are crucial in 
measuring the functionality of important biologically active proteins. Several experimental 
techniques are currently available for in vivo evaluation of protein folding within intact cells, 
mainly relying on intramolecular fluorescence resonance energy transfer (FRET) (Morris et 
al., 1982; Russwurm et al., 2007; Tsien 2009) of labeled residues or attached variants of green 
fluorescent protein (GFP), but none of these techniques can be optimally extended to 
imaging assays in intact living subjects. Protein complementation assays based on 
bioluminescent reporters are highly sensitive in measuring not only protein-protein 
interactions, they can also be efficiently used for studying protein foldings in intact cells and 
in living animals by imaging. The application of protein complementation assays based on 
bioluminescent reporters are more generalizable for measuring protein folding, but can be 
used for imaging of protein folding in intact living subjects. The ability to detect, locate, and 
quantify protein folding in the setting of a whole living animal model has important 
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implications: (1) to characterize the functional aspects of the fundamental process of protein 
folding, including the study of biologically relevant and important factors, within realistic 
and relatively undisturbed confines of cells that are also present in the midst of fully 
functional and intact whole-body physiological environments; and (2) to accelerate the 
evaluation in living animal models of emerging novel classes of drugs that promote folding 
and conformational stability of proteins (e.g., those directed at the molecular chaperone heat 
shock protein 90 (Hsp90)). Emerging strategies for molecular imaging of biological processes 
in living small animal models of disease offer many distinct advantages over conventional 
in vitro and cell culture experimentation. 
In conclusion, we previously identified suitable split sites in the molecule of hRLUC that 
generated an N- terminal 229-residue fragment (N-hRLUC) with minimal independent 
activity and an inactive C- terminal 82-residue fragment (C-hRLUC) of the reporter protein. 
Together, they were able to produce significant recovered activity through assisted 
complementation. Later we used these reporter fragments along with reporter fragments of 
firefly luciferase (FLUC) to test protein-protein interactions mediated in different 
experimental settings: 1) proteins that spontaneously interact; 2) proteins that interact when 
a small molecule is present; 3) protein-protein interactions that are blocked by small 
molecules; 4) proteins-protein interactions that are mediated by phosphorylation; and 5) 
protein hydroxylation that is mediated protein-protein interactions (Table 3). After a 
thorough investigation of the system for studying protein-protein interactions, we 
demonstrated that the normal conformational changes during protein folding, which result 
in the close approximation of amino and carboxy termini of the proteins, can be measured 
by using intramolecular complementation of correctly oriented chimeric split imaging 
reporters in a strategy to detect, locate, time, quantify, and image protein folding in living 
subjects. As we have extensively studied ligand induced estrogen receptor (ER) folding in 
cells and in living animals, the following section will explain in detail the intramolecular 
folding of ER in response to different steroidal and non-steroidal ligands in cells and in 
living animals. 
3.4 Protein complementation assays to study ligand- induced estrogen receptor 
folding 
Estrogens are responsible for the growth, development, and maintenance of the 
reproductive, skeletal, neuronal, and immune systems as well as several other systems of 
the body. The physiological effects of these hormones are mediated by the estrogen receptor 
(ER), which is a ligand-inducible nuclear transcription factor (Tsai and O'Malley 1994). In 
the classical pathway of steroid hormone action, 17┚-estradiol (E2), hormones, and a variety 
of other estrogens bind to the ligand-binding domain (LBD) of ER, leading to its 
dimerization and subsequent binding to a specific regulatory sequence in the promoters of 
ER target genes known as the estrogen response elements (Gronemeyer 1991; Schuur et al., 
2001) that then trigger activation or repression of many downstream target genes 
(Brzozowski et al., 1997). The deficiency or excess of estrogens can lead to various 
pathological conditions, including osteoporosis and breast carcinomas (Beck et al., 2005), 
making ER a major cellular therapeutic target. ER activity in regulating target genes is 
modulated by the binding of both steroidal and synthetic non-steroidal ligands. The ligand 
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binding with ERs induces various conformations that control their interactions with 
transcriptional co-regulators. Estrogen receptors (ER┙ and ER┚) regulate the expression of a 
number of gene products required for the growth of cells in response to the endogenous 
estrogen 17┚-estradiol (E2). The crystal structures of ER ligand-binding domains (ER-LBDs) 
complexed with different ER ligands provide useful insight into the design and synthesis of 
new ligands. Although computer modeling and structure-based design can help predict 
molecular interactions and structure-activity relationships, the pharmacological actions of 
these ligands are unpredictable and require further biological evaluation. Thus, it remains 
important to fully characterize nuclear hormone receptor ligands in cells and in animal 
models before considering their use in humans. Several assay systems are currently 
available to characterize ER ligands for their biological activity through ER in vitro and in 
cell-based assays, but only a few can be directly extended for use in animals. We 
approached this issue by using bioluminescence imaging to study estrogen biology in living 
animals. Our system involves monitoring luminescence that derives from intramolecular 
complementation of a split luciferase gene that is activated by ligand-induced folding of the 
ER-LBD, and the responsiveness of various versions of this ligand sensor system to selected 
ER ligands was validated in cellular systems. 
 
Split-Reporter 
Proteins 
Imaging 
Modality 
Protein-
Protein 
Interactions 
Nature of interaction 
Firefly Luciferase 
(FLUC) 
Bioluminescence Id/myoD  Spontaneous interaction 
Renilla Luciferase 
(RLUC) 
Bioluminescence FRB/FKBP12 Rapamycin mediated interaction 
Gaussia Luciferase 
(GLUC) 
Bioluminescence pVHL/HIF1- Hydroxylation mediated interaction 
Green Fluorescent 
Protein (GFP) 
Fluorescence Ras/Raf Phosphorylation mediated interaction 
Red Fluorescent 
Protein (RFP) 
Fluorescence Hsp90/p23 Spontaneous interaction 
Thymidine Kinase 
(HSV1-TK) 
PET p53/SV40-Tag Spontaneous interaction 
  ER/ER Estrogen mediated homodimerization 
  TK/TK Spontaneous dimerization 
  ER-Folding Estrogen mediated intramolecular 
folding 
  IRS1/SH2 Phosphorylation mediated interaction 
  c-myc/GSK3 Phosphorylation mediated interaction 
Table 3. List of optical and PET based split reporter complementation systems developed 
and protein-protein interactions and protein foldings studied 
The crystallographic studies with ER–LBD have shown that conformation of helix 12 (H12) 
is critical in responses observed with various ER ligands (Brzozowski et al., 1997; Pike et al., 
2000; Shiau et al., 1998). The conformation of H12 behaves as a “molecular switch” that  
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either prevents or enhances the binding of ER to an array of co-activator proteins, which 
then activates transcription of many downstream estrogen-regulated genes responsible for 
cell growth. Given the critical role of H12 in ER signaling, we reasoned that it might be 
feasible to develop an intramolecular ER folding sensor with specific split reporter 
complementation patterns to study ligand pharmacology based directly on the 
conformational changes of H12 in response to different ligands (Figure 6). We used a split 
synthetic Renilla luciferase (RLUC) and Firefly luciferase (FLUC) complementation system, 
which we previously developed and validated (Paulmurugan and Gambhir 2007; 
Paulmurugan et al., 2002a), to test this hypothesis by assaying ligand-induced RLUC/FLUC 
complementation in cell lysates, intact cells, and cell implants in living mice by noninvasive 
bioluminescence optical imaging. The validated ER intramolecular folding sensors can also 
be used to distinguish ligand pharmacology in cell culture studies and cell implants in 
living animals treated with different ER ligands, agonists, selective ER modulators (SERMs), 
and pure antiestrogens. In adapting this bioluminescence ER ligand sensor system for in vivo 
use, we developed a version that contained a carefully developed single amino acid  
 
Fig. 6. Schematic representation of the hypothetical model of ligand-induced intramolecular 
folding of ER that leads to split firefly luciferase (FLUC) complementation. The N- and C-
terminal fragments of split-FLUC were fused to the N- and C- terminus, respectively, of the 
hER┙-LBD of various lengths (amino acids 281–549 or 281–595). Binding of ligands to the 
LBD of ER in the intramolecular folding sensor (N-RLUC-hER-C-RLUC) induces different 
potential folding patterns in the LBD based on ligands properties of potency and 
biocharacter. This folding leads to split -FLUC complementation for ER antagonist/SERMS 
(C), low complementation for ER agonist (A), and no complementation for partial ER 
agonist/antagonist (B) with the selective folding sensor. Even though the distance between 
the N- and C-FLUC fragments after binding with partial agonist (B) is smaller than that of 
agonists (A), this model depicts the importance of the orientations of the split-FLUC 
fragments in achieving complementation.  
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mutation in the ER┙-LBD, G521T. This ER mutant was selected to be essentially 
unresponsive to E2, so that it could be used in mice without interference from the 
endogenous ligand, while being responsive to certain non-steroidal estrogens such as 
diethylstilbestrol (DES) and SERMs, making it possible to study their activity in vivo by 
bioluminescence (Paulmurugan and Gambhir 2006; Paulmurugan et al., 2008). 
We have developed and validated two hER intramolecular folding sensors that can be used 
to distinguish ER ligand pharmacology. These receptor sensors can be directly translated 
from cell culture studies to molecular imaging in small living subjects. In this study we used 
an ER-based split reporter complementation strategy to follow the position of H12 within 
the ER–LBD to detect changes in the receptor structural folding in response to ligand 
binding. The longer construct with the F domain (281–595) appears ligand-pharmacology-
independent, whereas the shorter construct without the F domain (281–549) leads to the 
highest levels of split luciferase complementation in response to SERMs, moderate levels for 
agonists, and minimal levels for pure antiestrogens (Paulmurugan and Gambhir 2006). We 
validated these intramolecular folding sensors with various ER ligands in both transiently 
and stably transfected 293T kidney cells, and MDA-MB-231 (ER-negative) and MCF-7 (ER-
positive) breast cancer cells. To extend the folding sensor for applications in living animals, 
we incorporated a previously undescribed mutant of hER (G521T) into the folding sensor 
that was insensitive to circulating endogenous estrogen but retained its ability to distinguish 
SERMs from synthetic agonists. Alternatively, ovariectomized mice can likely be used with 
the wild-type hER with minimal competition from endogenous estrogens while retaining 
the ability to study estrogen-like drugs.  
To date, several in vitro assays have been developed for screening ER ligands by using either 
purified ER┙ protein or ER isolated from cell lysates (Inoue et al., 1983; Krey et al., 1997; 
Nasir and Jolley 1999; Nichols et al., 1998). Limited fluorescence-based assays (Zhou et al., 
1998) have been developed to measure receptor conformational changes (23) and 
recruitment of coactivator peptides (Bai and Giguere 2003; Weatherman et al., 2002; Zhou et 
al., 1998) in the full-length hER┙ within cell culture (Michalides et al., 2004). Other assays 
have been designed to study the effects of synthetic ligands on ER transcription through the 
activation of downstream target genes (Awais et al., 2004). However, most of these reported 
assays are not suitable for quantitative, high-throughput screening of ER ligands in intact 
cells and especially in living subjects through noninvasive molecular imaging. A 
nontranscriptional assay containing fusion chimeras of either Flp recombinase (Logie et al., 
1998) or Cre recombinase (Kemp et al., 2004) with a truncated mouse ER┙ (amino acids 281–
599) has been reported and used for regulating the recombination of reporter genes in cells 
and living animals. This system demonstrates high background activity even before the 
addition of ER ligands, mainly through enzymatic amplification, thus limiting its dynamic 
range in response to different ER ligands. We developed an analogous fusion chimera by 
fusing a truncated version of hER (amino acids 281–595) with FLUC, which leads to 
luciferase activity that is 104-fold greater than background (mock-transfected cells) even 
before the addition of ligands. To our knowledge, only one study has reported the 
construction of mutant versions of hER (G521R and G521V) for selective ER ligand binding 
using a fusion chimera containing hER251–595 with Flp recombinase enzyme (28). 
Incorporation of the same mutation into our intramolecular folding sensor (N-RLUC-hER281–
595-C-RLUC) led to nearly complete abolishment of signal for all ER ligands (hERG521R) and a 
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significant reduction in signal (77–89%) for all agonist activities (hERG521V) relative to wild 
type hER. We constructed intramolecular folding sensors using the hERG521 mutants with 19 
different possible amino acids. We found that the replacement of hERG521 with threonine 
leads to nearly complete abolishment of the E2-induced RLUC complementation but only a 
10–20% reduction for all other ER ligands studied. Subsequently, 293T cells stably 
expressing this intramolecular folding sensor (N-RLUC-hER281–549/G521T-C-RLUC) were 
generated for imaging hER┙/ligand complexes in living animals. 
The advantages of the intramolecular folding sensor strategy that has been developed and 
validated include the following: (i) it is real-time (because RLUC exhibits flash kinetics) and 
quantitative; (ii) it can be used to distinguish binding of agonists, SERMs, and pure 
antiestrogens; (iii) it can be adapted for studying ligand binding to hER in living animal 
models by molecular imaging, and thus pharmacokinetic properties of each drug/ligand 
can be examined; (iv) it allows for a high-throughput strategy for screening/comparing 
different ER ligands and drugs in multiple cell lines; (v) it allows direct transition from cell 
culture studies to small living subjects because it is based on a bioluminescence split 
reporter strategy; and lastly, (vi) it will allow for applications using transgenic models that 
incorporate the intramolecular folding sensor. In addition, the availability of other split 
reporters with different properties and substrate specificities should allow multiplexing 
with other reporter assays. 
The limitations with using split RLUC as the reporter gene regarding efflux of its substrate 
coelenterazine were resolved by showing experiments that resulted in no significant relation 
between the RLUC complementation and the multidrug resistance systems (Pichler et al., 
2004). In addition, the intramolecular folding system was also studied with the improved split 
FLUC fragments by replacing RLUC fragments. Both systems showed equal sensitivity in 
different cell culture experiments. The FLUC fragments showed more detectable signal in 
mouse experiments than RLUC because of more light penetration through tissues, due to the 
more red-shifted wavelengths of FLUC. Also, the FLUC-based folding system showed greater 
efficiency in differentiating ER ligands in living mice. It is also possible that the exact locations 
(cytosolic vs. nuclear) of our fusion reporter proteins may affect the results obtained, and this 
will need to be explored in future studies. In addition, for some applications in vivo, the 
developed strategies may have difficulty in distinguishing agonists from background, and this 
potential problem needs to be investigated with testing of additional drugs. 
3.5 Reporter protein complementations to monitor multi-protein interactions  
The availability of multiple bioluminescent reporters (FLUC, RLUC, GLUC, and possibly 
VLUC) can be easily adopted for studying multiple proteins involved in a cellular network 
(e.g., Hsp90 chaperon multi-protein complex has more than 50 proteins) (Goetz et al., 2003) 
by multiplexing reporter combinations. The use of multiple reporters not only provides the 
interaction between more than two proteins, but can also provide more precise informations 
to modulate the effect that one set of protein may exert on other sets of proteins involved in 
the same complex. In addition, it can also be used to extract the distances among different 
proteins involved in a complex based on the amount the complementation signals produced 
from each set of proteins (Figure 7).  We are actively exploring multi-protein interactions by 
multiplexing several combinations, and we hope to soon publish results about this strategy 
and its feasibility. 
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Fig. 7. Schematic representation of two split-reporter complementation systems to detect the 
interactions between several proteins involved in a multi-protein interaction complex. In 
this strategy, the results of two reporter protein complementations measured 
simultaneously between two reporters (Split-FLUC and Split-RLUC) induced by small 
molecules can predict possible arrangements of different proteins involved in this complex 
(Hsp90, p23, Estrogen Receptor, p53, and HDM2). Four different hypothetical models have 
been proposed based on possible theoretical complementations by these reporters in 
response to drugs which modulate Hsp90/p23 interaction (17AAG), p53/ER interaction 
(E2), and p53/HDM2 interaction (Nutlin 3). 
4. Bioluminescence resonance energy transfer 
Bioluminescence Resonance Energy Transfer (BRET) technology involves the nonradioactive 
transfer of energy between donor and acceptor molecules by the Förster mechanism (46). The 
energy transfer primarily depends on the following: (1) an overlap between the emission and 
excitation spectra of the donor (bioluminescence) and acceptor (Fluorophore or a fluorescent 
protein) molecules, respectively; (2) the proximity of < 100 Å between the donor and the 
acceptor entities; and (3) the conformational orientation light emission with the acceptance end 
of the fluorescence entity. As BRET-based technology assumes more prominent roles in the 
field of studying PPIs, many commercial vendors are developing new instrumentations for 
measuring BRET ratios, which are generally low-intensity signals. BRET measurements are 
usually obtained with a microplate reader equipped with specific filter sets for detection of the 
donor and acceptor emission peaks. This cellular assay has been applied to real-time imaging 
of cells, high-throughput screening of drugs, and small animal and plant models. There are 
several combination of BRET involving Renilla luciferase and green fluorescent protein and 
Firefly luciferase with variants of red fluorescent proteins developed for studying protein-
protein interactions. The BRET2 system (Biosignal Packard Montreal, Canada) using renilla 
luciferase (RLUC) as a bioluminescent donor and mutant GFP2 as a fluorescent acceptor was 
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adapted for expression in mammalian cells and characterized by a significantly red-shifted 
Stokes shift that emits transferred energy at 508 nm. The resonance energy transfer from the 
reaction of the reconstructed RLUC protein with its substrate Deep Blue Coelenterazine (DBC) 
excites the GFP2 protein, as the two fused proteins Id and MyoD, or FKBP12 and FRB which 
interact in the presence of a small molecule mediator (rapamycin). Our lab also demonstrated 
the ability to detect signal from PPIs in cultured cells, as well as from the surface and deeper 
tissues of small living animals with implanted cells over expressing the fusion constructs (For 
further details, read (De et al., 2009; Dragulescu-Andrasi et al., 2011). 
Our lab has recently showed that the BRET2 assay sensitivity can be significantly improved 
by using RLUC mutants with improved quantum efficiency and/or stability (eg, RLUC8 
and RLUCM) as a donor. To extend the time of light measurement, we also developed 
CLZ400 (also known as bisdeoxycoelenterazine) analogs, showing that signal from our 
improved BRET2 vector can be monitored for up to 6 hours. This approach, currently 
undergoing continuing validation, should have important implications for the study of PPIs 
in cells maintained in their natural environment, particularly if it can be effectively applied 
for the evaluation of new pharmaceuticals. Most recently, further advances in this field have 
led us to develop a high photon efficiency, self-illuminating fusion protein combining a 
mutant red fluorescent protein (mOrange) and a mutant RLUC (RLUC8). This new BRET 
fusion protein (BRET3) exhibits a several fold improvement in light intensity in comparison 
to existing BRET fusion proteins. BRET3 also exhibits the most red-shifted light output (564 
nm peak wavelength) of any reported bioluminescence protein that uses its natural 
coelenterazine substrate, a benefit that can be demonstrated at various tissue depths in small 
animals. 
5. Future directions in bioluminescence imaging 
Molecular imaging has been recognized as an important and exciting area of bio-medical 
research, mainly because of its ability to visually represent, characterize, and quantify 
biological processes in living subjects.  Techniques such as Positron Emission Tomography 
(PET), Single-photon Emission Computed Tomography (SPECT), and Magnetic Resonance 
Imaging (MRI) have been extensively used in the clinic for several diagnostic and disease 
monitoring processes; all these systems explore intracellular proteins or other molecules as 
probes for the signal. Reporter genes (Bioluminescence, fluorescence, and PET), on the other 
hand, are capable of precisely monitoring sub-cellular processes and their native functional 
actions in cells, and imaging them in living animals. Challenges, however, remain in 
delivering these proteins in cells without perturbing the cellular microenvironments. Another 
obstacle is in generating sufficient sensitivity to measure theses signals, especially in living 
animals. Problems associated with the modulations in the cellular microenvironment are also 
tricky, but may be minimized by expressing few copies and weighing the sensitivity. The 
continuing development of new high-sensitivity instruments with tomographic imaging 
capabilities and improved spatial resolutions will play an important role in expanding the 
applications of bioluminescent reporters and exploiting their unique ability to precisely image 
the sub-cellular processes in their native microenvironment.  
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